Invention Grant
- Patent Title: Use of melatonin for the treatment of tumors
-
Application No.: US16498825Application Date: 2018-04-02
-
Publication No.: US11234964B2Publication Date: 2022-02-01
- Inventor: Germaine Escames Rosa , Darío Acuña Castroviejo , Ana Guerra-Librero Rite , Beatriz Irene Fernández Gil , Javier Florido Ruiz
- Applicant: UNIVERSIDAD DE GRANADA
- Applicant Address: ES Granada
- Assignee: UNIVERSIDAD DE GRANADA
- Current Assignee: UNIVERSIDAD DE GRANADA
- Current Assignee Address: ES Granada
- Agency: Amster Rothstein & Ebenstein LLP
- Agent Gary J. Gershik
- Priority: ESES201730598 20170331
- International Application: PCT/ES2018/070289 WO 20180402
- International Announcement: WO2018/178497 WO 20181004
- Main IPC: A61K31/4045
- IPC: A61K31/4045 ; A61P35/00 ; A61K9/00 ; A61K45/06
Abstract:
The present invention relates to the use of melatonin for the preparation of a pharmaceutical composition suitable for intratumoral administration for the treatment of tumors. This composition comprises high concentrations of melatonin, melatonin derivatives or metabolites, such that melatonin exerts an oxidizing effect, increasing the production of free radicals and activating cell death.
Public/Granted literature
- US20210106562A1 USE OF MELATONIN FOR THE TREATMENT OF TUMOURS Public/Granted day:2021-04-15
Information query
IPC分类:
